Other symptoms may include abnormal skin patches, itching, and changes in skin colour
Curr Opin Mol Ther 12:790797 Onge EL, Miller SA (2010) Albiglutide: a new GLP-1 analog for the treatment of type 2 diabetes
The three drugs currently approved by the FDA to treat alcohol use disorder are under-utilized
This binding triggers a cascade of signals that reduce hunger hormones like ghrelin while amplifying satiety signals, causing you to feel fuller faster and remain satisfied longer between meals
Tirzepatide has shown promising results in clinical trials, offering a new therapeutic option for those struggling to achieve glycemic control with existing treatments
Activation of these signaling pathways promotes the secretion of gut-derived hormones such as glucagon-like peptide-1 (GLP-1), peptide YY (PYY), and serotonin